CTRL-LABS BUYS ARMBAND IP FROM THALMIC LABS
CTRL-Labs buys armbands IP (Internet Protocol) from Thalmic Labs, CTRL-Labs is a New York-based startup which consists of many neuroscientists who according to reports are aiming to build a wrist-worn input device that could potentially translate electrical signals from the human body into a computer input. The organization (startup) had its funding from GV, Vulcan Capital,
Thalmic Labs had earlier tried its best to produce a gestural armband controller considered the future of user input, but now, another startup has acquired the parent product and customer data. CTRL-Lab launched its development Kit, in December, precisely for its device similar to ‘Myo armband’ but with more design specification enhanced in its sensing capability. The
Meanwhile, Thalmic Labs had its ambition focused on extracting input from the human body’s electrical signal, while CTRL-Labs focus more on the technology. However, the technology CTRL-Labs seeks to translates sweeping arm movements into mechanisms.
Another reason why CTRL-Labs bought armbands IP is its hope that by integrating the technology into future development device, developers in the future will have more options for functionality as the company strives to achieve its more complex development.
Thalmic Labs also known as North, has been able to raise about two hundred million dollars ($200 million) according to reports. The purchase of this technology from Thalmic Labs indicates the end of its era, though the company has made huge money within a short period. Currently, the company looks to focus more on its new smart glasses by dumping its ‘Myo armband’, so instead of further developing its armband, the effort is made towards its current choice as its team strives to enhance its smart glasses. It’s equally understood Thalmic Labs glasses start at $599 and $799 respectively for its prescription lenses.
As of the time of this report, it’s understood the cost at which CTRL-Labs acquired armband IP wasn’t disclosed based on CTRL-Labs executive ‘Josh Duyan’s’ decision.
- What is your take on CTRL-Labs deal?